SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Stay informed with null’s coverage and analysis for Fortune.
Health
How big data and an A-list board turned struggling NYU Langone into a $14 billion hospital powerhouse
By
Erika Fry
Features
Will AI ever cure cancer? The multibillion-dollar race to bring the first AI-discovered drug to market
By
Erika Fry
Magazine
Trump has promised to ‘knock out’ pharmacy benefit managers. How the drug middlemen became a $557 billion industry that its customers love to hate
By
Erika Fry
Health
20 innovative breakthroughs that will transform your health
By
Erika Fry
Features
How UnitedHealthcare and other mega-insurers came to dominate the $4.5 trillion health care industry that Americans both hate and rely upon
By
Erika Fry
Magazine
How Eli Lilly went from pharmaceutical slowpoke to $791 billion juggernaut
By
Erika Fry
Features
America’s health system is still in crisis after its biggest cyberattack ever—but the ‘catastrophe’ is just a blip for the giant company that got hacked
By
Erika Fry
Features
What losing vision in one eye helped me understand about animal research
By
Erika Fry
Features
Why Big Pharma can’t quit the lab monkey business
By
Erika Fry
Features
Is Big Pharma’s favorite lab monkey endangered?
By
Erika Fry
Magazine
Big Pharma’s great lab monkey shortage: A crackdown on smuggling is causing chaos in America’s vital drug development pipeline
By
Erika Fry
Conferences
Addressing the social and racial barriers to health care equity
By
Erika Fry
Features
She was overwhelmed with loneliness after losing her husband of 65 years. Then a robot companion changed her life
By
Erika Fry
Features
60% of Americans battling drug or alcohol addictions also have jobs. Here are the professions with the highest rates of substance-use disorder
By
Erika Fry
Magazine
As the opioid epidemic worsens, recovery-friendly policies are the next frontier in workplace inclusion
By
Erika Fry